Document is current
Any future updates will be listed below
-
Authors
Schoenfeld, Joshua D.
Ravichandran, Vignesh
Tarcan, Zeynep
Sahin-Ozkan, Hulya
Richards, Allison L.
Bilani, Nadeem
Chou, Joanne F.
O’Connor, Catherine A.
McManamon, David
Varghese, Anna M.
Keane, Fergus
D’Angelica, Michael I.
Jarnagin, William R.
Drebin, Jeffrey
Reidy-Lagunes, Diane
Wei, Alice C.
Chalasani, Sree B.
Balogun, Fiyinfolu
Park, Wungki
Yu, Kenneth H.
Soares, Kevin
Donoghue, Mark T. A.
Iacobuzio-Donahue, Christine
Stadler, Zsofia K.
Capanu, Marinela
Basturk, Olca
O’Reilly, Eileen M.
-
Funding
Funding for this research was provided by:
National Cancer Institute (NIH T32-CA009207)
National Cancer Institute (NIH P50 CA257881-01A1)
National Cancer Institute (NIH P50 CA257881-01A1)
- License Information
-
More Information
Article History
Received: 13 January 2026
Accepted: 26 January 2026
First Online: 8 February 2026
Competing interests
: J.D.S has consulted for Hoplite Healthcare and is on the medical advisory board for OpenEvidence. D.R.L. is on the scientific advisory board for Exelexis, Novartis, and Wren Laboratories; received research support from Novartis, Merck. Z.K.S has intellectual property rights in SOPHiA Genetics and serves as an Associate Editor for JCO Precision Oncology and as a Section Editor for UpToDate. Z.K.S immediate family member serves on the Board of Directors for Adverum Biotechnologies, is Co-Founder, CMO and President for Blue Gen Therapeutics Foundation, and serves as a consultant in Ophthalmology for Apellis, Novartis, Outlook Therapeutics, Optos, and Regeneron outside the submitted work. E.M.O has received research funding from Genentech/Roche, BioNTech, AstraZeneca, Arcus, Elicio, Parker Institute, NIH/NCI, Digestive Care, Break Through Cancer, Agenus, Amgen, and Revolution Medicines; consulted (mostly uncompensated) for Arcus, AstraZeneca, Ability Pharma, Alligator BioSciences, Agenus, BioNTech, Ipsen, Ikena, Merck, Moma Therapeutics, Novartis, Leap Therapeutics, Astellas, BMS, Revolution Medicines, Regeneron, and Tango; received travel support from BioNTech and Arcus; other support from American Association of Cancer Research (AACR), American Society of Clinical Oncology (ASCO), Imedex, Research To Practice, and Stand Up to Cancer (SU2C); and her spouse has received support from AbbVie. All other authors declare no potential conflicts of interest.
